Screening for nasopharyngeal carcinoma;DEPISTAGE DES CARCINOMES INDIFFERENCIES DU NASOPHARYNX

Bulletin du Cancer

Volumn 83, Issue 5, 1996, Pages 344-351

  Sasco, A J ^a  

^a INSERM   (France)

Author keywords

epidemiology; nasopharyngeal carcinoma; screening; serology

Indexed keywords

VIRUS ANTIBODY; IMMUNOGLOBULIN A; TUMOR MARKER;

CANCER SCREENING; CHINA; EPSTEIN BARR VIRUS; HUMAN; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; REVIEW; SEROLOGY; ADULT; AGED; BLOOD; CARCINOMA; EPIDEMIOLOGY; IMMUNOLOGY; MALE; MASS SCREENING; MIDDLE AGED; NASOPHARYNX TUMOR; PREDICTION AND FORECASTING; RISK FACTOR;

ADULT; AGED; CARCINOMA; CHINA; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN A; MALE; MASS SCREENING; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0030140898     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Ammatuna P, de Thé G, Speciale R, Sammartano F, Arista S, Zerillo G. Serological and immunohistological assessment of Epstein-Barr virus infection in Sicilian patients with suspected nasopharyngeal carcinoma. Microbiologica 1988;11:89-94
2. Armstrong RW, Kannan Kutty M, Armstrong MJ. Self-specific environments associated with nasopharyngeal carcinoma in Selangor, Malaysia. Soc Sci Med 12D:1978; 149-56
3. Armstrong W, Armstrong MJ, Yu MC, Henderson BE. Salted fish and inhalants as risk factors for nasopharyngeal carcinoma in Malaysian Chinese. Cancer Res 1983;43: 2967-70
4. Bogger-Goren S, Gotlieb-Stematsky T, Rachima M, Barkowsky H, Schlomo-David J. Nasopharyngeal carcinoma in Israel: epidemiology and Epstein-Barr virus related serology. Eur J Cancer Clin Oncol 1987;23:1277-81
5. Cevenini R, Donati M, Caliceli U, Moroni A, Tamba I, Rumpianesi F. Evaluation of antibodies to Epstein-Barr virus in Italian patients with nasopharyngeal carcinoma. J Inf 1986;12:127-31
6. Chan CK, Mueller N, Evans A et al. Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma. Cancer Causes and Control 1991;2:125-31
7. Chan SH. Screening for NPC. Ann Acad Med Singapore 18, 80-82, 1989.
8. Chan SH, Chew CT, Prasad U, Wee GB, Srinivasan N, Kunaratnam N. HLA and nasopharyngeal carcinoma in Malays. Br J Cancer 1985;51:389-92
9. Chan SH, Day NE, Kunaratman N, Chia KB, Simons MJ. HLA and nasopharyngeal carcinoma in Chinese. A further study. Int J Cancer 1983;32:171-6
10. Chen GJ, Chen JY, Hsu MM et al. Epidemiological characteristics and early detection of nasopharyngeal carcinoma in Taiwan. In: Wolf GT, Carey TE, eds. Head and Neck Oncology Research. Amsterdam-Berkeley: Kunler Publications, 1988:505-13
11. Chen JY, Chen CJ, Liu MY et al. Antibody to Epstein-Barr virus-specific DNase in patients with nasopharyngeal carcinoma and control groups. J Med Virol 1987;23:11-22
12. Chen JY, Chen CJ, Liu MY et al. Antibody to Epstein-Barr virus-specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan. J Med Virol 1989;27:269-73
13. Coates HL, Pearson GR, Neel HB, Weiland MD, Devine KD. An immunologic basis for detection of occult primary malignancies of the head and neck. Cancer 1978;41:912-8
14. Cole P, Morrison AS. Basic issues in population screening for cancer. JNCI 1980;64:1263-72
15. Coyle PV, Wyatt D, Connolly JH, Lynch GA. Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma in northern Ireland. IJMS 1987;156:182-4
16. Djojopranoto M, Sœsilowati. Nasopharyngeal cancer in East Java (Indonesia). In: Muir CS, Shanmugaratnam KS, eds. Cancer of the nasopharynx. Munksgaard, Copenhagen: UICC Monograph Series, Vol 1, 1967:43-6
17. Ellouz R, Cammoun M, Ben Attia R, Bahi J. Nasopharyngeal carcinoma in children and adolescents in Tunisia: clinical aspects and paraneoplastic syndrome. In: de Thé G, Ito Y, eds. Nasopharyngeal carcinoma: Etiology and control. IARC Sci Pub no 20. Lyon: International Agency for Research on Cancer, 1978:115-30
18. Faggioni A, Corradini C, Venanzoni M et al. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and EBV serology. J Exp Pathol 1987;3:471-7
19. Fong YY, Walsh FO. Carcinogenic nitrosamines in Cantonese salt-dried fish. Lancet 1971;ii:1032
20. Geser A, Charnay N, Day NE, de Thé G. Environmental factors in the etiology of nasopharyngeal carcinoma: report on a case-control study in Hong Kong. In: de Thé G, Ito Y, eds. Nasopharyngeal carcinoma: etiology and control. IARC Sci Pub no 20. Lyon: International Agency for Research on Cancer 1978:213-29
21. Gurtsevich V, Ruiz R, Stepina V et al. Epstein-Barr viral serology in nasopharyngeal carcinoma patients in the USSR and Cuba and its value for differential diagnosis of disease. Int J Cancer 1986;37:375-81
22. Hadar T, Rahima M, Kahan E et al. Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigen in nasopharyngeal carcinoma patients. J Med Virol 1986;20:329-39
23. Henderson BE, Louie E, SooHoo Jing J, Buell P, Gardner MB. Risk factors associated with nasopharyngeal carcinoma. N Engl J Med 1976;295:1101-6
24. Henle W, Henle G. Epstein-Barr virus and human malignancies. Adv Viral Oncol 1985;5:201-38
25. Hidayatalla A, Malik MOA, El Hadi AE, Osman AA, Hutt MSR. Studies on nasopharyngeal carcinoma in the Sudan. I. Epidemiology and Aetiology. Eur J Cancer Clin Oncol 1983;19:705-10
26. Hildesheim A, West S, DeVeyra E et al. Herbal medicine use, Epstein-Barr virus, and risk of nasopharyngeal carcinoma. Cancer Res 1992;52:3048-51
27. Ho JHC. Genetic and environmental factors in nasopharyngeal carcinoma. In: Nakahara W, Nishioka K, Hirayama T et al, eds. Recent advances in human tumor virology and immunology. Tokyo: University of Tokyo Press, 1971: 275-95
28. Ho JHC. Nasopharyngeal carcinoma (NPC). Adv Cancer Res 1972;15:57-92
29. Ho JHC. Stage classification of nasopharyngeal carcinoma: a review. In: de Thé G, Ito Y, eds. Nasopharyngeal carcinoma: etiology and control. IARC Sci Pub no 20. Lyon: International Agency for Research on Cancer 1978:99-113
30. Hu MS, Huang HL. Retrospective study on the etiological factors of nasopharyngeal carcinoma. New Med (Canton) 1972;12:10
31. Huang DP, Ho JHC, Saw D, Teoh TB. Carcinoma of the nasal and paranasal regions in rats fed Cantonese salted marine fish. In: de Thé G, Ito Y, eds. Nasopharyngeal carcinoma: etiology and control. IARC Sci Pub no 20. Lyon: International Agency for Research on Cancer 1978: 315-328
32. Ireland B, Lanier AP, Knutson L, Clift SE, Harpster A. Increased risk of cancer in siblings of Alaskan native patients with nasopharyngeal carcinoma. Int J Epidemiol 1988;17:509-11
33. Jeannel D, Hubert A, de Vathaire F et al. Diet, living conditions and nasopharyngeal Carcinoma in Tunisia. A case-control study. Int J Cancer 1990;46:421-5
34. Korbi S, Descoteaux-Chatti D. Le cancer dans le centre tunisien. Sousse: éd Copie, 1995
35. Lanier A, Bender T, Talbot M et al. Nasopharyngeal carcinoma in Alaskan Eskimos, Indians and Aleuts: a review of cases and study of Epstein-Barr virus, HLA and environmental risk factors. Cancer 1980;46:2100-6
36. Lanier A, Clift S, Ireland B et al. Cancer risks and EBV antibody patterns in NPC families. In: Proceedings of the Second Symposium on EBV and associated malignant diseases. October 1986, Saint-Petersburg, FL, 1986:85-9
37. Lee HP, Day NE, Shanmugaratnam K, eds. Trends in cancer incidence in Singapore, 1968-1982. IARC Sci Pub no 91. Lyon: International Agency for Research on Cancer, 1988
38. Levine PH, Connelly RR, Milman G, Easton J. Epstein-Barr virus serology in the control of nasopharyngeal carcinoma. Cancer Detect Prev 1988;12:357-62
39. Lin TM, Chen KP, Lin CC et al. Retrospective study on nasopharyngeal carcinoma. JNCI 51, 1973:1403-8
40. Mabuchi K, Bross DS, Kessler II. Cigarette smoking and nasopharyngeal carcinoma. Cancer 1985;55:2874-6
41. Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC. Report on a workshop of the UICC project on evaluation of screening for cancer. Int J Cancer 46, 1990:761-9
42. Naegele RF, Champion J, Murphy S, Henle G, Henle W. Nasopharyngeal carcinoma in American children: Epstein-Barr virus-specific antibody titers and prognosis. Int J Cancer 1982;29:209-12
43. Nielsen NH, Mikkelsen F, Hansen JPH. Nasopharyngeal carcinoma in Greenland: the incidence in an Arctic Eskimo population. Acta Pathol Microbiol Scand, Sect A, 1977;85:850-8
44. Ning JP, Yu MC, Wang QS, Henderson BE. Salted fish and other risk factors for nasopharyngeal carcinoma in Tianjin, a low risk region of China. JNCI 1990;82:291-6
45. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, eds. Cancer Incidence in Five Continents, Vol VI. IARC Sci Pub no 120. Lyon: International Agency for Research on Cancer 1992
46. Pi GH, Zeng Y, Wolf H. Detection of IgA antibody to EBV membrane antigen using Staphylococcus aureus preabsorbed sera is closely associated with nasopharyngeal carcinoma. J Virol Methods 1987;15:33-9
47. Purchase IFH, Paddle GM. Does formaldehyde cause nasopharyngeal cancer in man? Cancer Letters 1989;46:79-85
48. Roush GC, Walrath J, Stayner LT, Kaplan SA, Flannery JT, Blair A. Nasopharyngeal cancer, sinonasal cancer and occupations related formaldehyde: a case-control study. JNCI 1987;79:1221-4
49. Sasco AJ. Risque iatrogène et dépistage: l'exemple de la mammographie. Rev Epidém et Santé Publ 1994;42:385-91
50. Sasco AJ, Day NE, Walter SD. Case-control studies for the evaluation of screening. J Chronic Dis 1986;39:399-405
51. Schaefer O, Hildes JA. Canada (Eskimos): Inuit Cancer Register 1950-1980. In: Parkin DM, ed. Cancer Occurrence in Developing Countries. IARC Sci Pub no 75. Lyon: International Agency for Research on Cancer 1986: 159-63
52. Shanmugaratnam K, Tye CY, Goh EH, Chia KB. Etiological factors in nasopharyngeal carcinoma: a hospital-based retrospective, case-control, questionnaire study. In: de Thé G, Ito Y, eds. Nasopharyngeal carcinoma: etiology and control. IARC Sci Pub no 20. Lyon: International Agency for Research on Cancer 1978:199-212
53. Sriamporn S, Vatanasapt V, Pisani P, Yongchaiyudha S, Rungpitarangsri V. Environmental risk factors for nasopharyngeal carcinoma: a case-control study in North Eastern Thailand. Cancer Epidemiol Biomark Prev 1992;1:345-8
54. de Vathaire F, Sancho-Garnier H, de Thé H et al. Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study. Int J Cancer 1988;42:176-81
55. Yan L, Xi Z, Drettner B. Epidemiological studies of nasopharyngeal cancer in the Guanzhou area, China. Preliminary report. Acta Otolaryngol (Stockh) 1989;107:424-7
56. Yu MC, Ho JHC, Lai SH, Henderson BE. Cantonese-styled salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res 1986; 46:956-61
57. Yu MC, Mo CC, Chong WX, Yeh FS, Henderson BE. Preserved foods and nasopharyngeal carcinoma: a case-control study in Guangxi, China. Cancer Res 1988;48:1954-9
58. Yu MC, Huang TB, Henderson BE. Diet and nasopharyngeal carcinoma: a case-control study. Int J Cancer 1989; 43:1077-82
59. Yu MC, Nichols PW, Zou XN, Estes J, Henderson BE. Induction of malignant nasal cavity tumours in Wistar rats fed Chinese salted fish. Br J Cancer 1989;60:198-201
60. Zeng Y. Seroepidemiological studies on nasopharyngeal carcinoma in China. Adv Cancer Res 1985;43:121-38
61. Zeng Y, Gong CH, Jan MG, Fun Z, Zhang LG, Li HY. Detection of Epstein-Barr virus IgA/EA antibody for diagnosis of nasopharyngeal carcinoma by immuno-autoradiography. Int J Cancer 1983;31:599-601
62. Zeng Y, Liu YX, Liu CR et al. Application of immunoenzymatic method and immunoautoradiographic method for the mass survey of nasopharyngeal carcinoma. Chinese J Oncol 1979;1:2-7
63. Zeng Y, Liu YX, Liu CR et al. Application of an immunoenzymatic method and immunoautoradiographic method for a mass survey of nasopharyngeal carcinoma. Intervirology 1980;13:162-8
64. Zeng Y, Ohshima H, Bouvier G et al. Urinary excretion of nitrosoamino acids and nitrate by inhabitants of high and low risk areas for nasopharyngeal carcinoma in southern China. Cancer Epidemiol Biomark Prev 1993;2:195-200
65. Zeng Y, Pi GH, Deng H et al. Epstein-Barr virus seroepidemiology in China. AIDS Res 1986;2:S7-S15
66. Zeng Y, Shen SJ, Deng H et al. Early nasopharyngeal carcinoma among IgA/VCA antibody-positive individuals detected by anticomplement immunoenzymatic method. Chin Med J 1984;97:155-7
67. Zeng Y, Zhang LG, Li HY et al. Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int J Cancer 1982;29:139-41
68. Zeng Y, Zhang LG, Wu YC et al. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China. Int J Cancer 1985;36:545-7
69. Zeng Y, Zhong JM, Li LY et al. Follow-up studies on Epstein-Barr virus IgA/VCA antibody-positive persons in Zangwu County, China. Intervirology 1983;20:190-4
70. Zhu XX, Zeng Y, Wolf H. Detection of IgG and IgA antibodies to Epstein-Barr virus membrane antigen in sera from patients with nasopharyngeal carcinoma and from normal individuals. Int J Cancer 1986;37:689-91